Bingqing Hui

机构：Jiangsu Cancer Hospital, Nanjing Medical University · ORCID：0000-0001-7354-5237

发表论文 30 篇 · 总被引 1494 次 · h-index 21

代表论文

• Application of Animal Models in Cancer Research: Recent Progress and Future Prospects (2021 · Cancer Management and Research · 被引 135)
• RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4 (2019 · Cell Death and Disease · 被引 128)
• Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial (2023 · Journal for ImmunoTherapy of Cancer · 被引 109)
• CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy (2022 · OncoImmunology · 被引 96)
• Engineered exosomes for co‐delivery of PGM5‐AS1 and oxaliplatin to reverse drug resistance in colon cancer (2021 · Journal of Cellular Physiology · 被引 90)
• Long noncoding RNA MAPKAPK5‐AS1 promotes colorectal cancer proliferation by partly silencing p21 expression (2018 · Cancer Science · 被引 70)